Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.

Sci Rep · 2017 · PMC5686113 · PMID 29138515

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

2E,F ), we observed highly significant differences between SCLC and NSCLC cell lines in response to VE-822 and PF-477736 (Fig. 2I,J , respectively).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.